Pitched as catching more bowel cancer earlier by lowering the free national screening age.

The Policy: National Bowel Screening Policy — 2023 Election →

What it does:

• The change: the universal free bowel-screening age was lowered from 60 to 58.
• The catch: it was funded by ending a programme that gave Māori and Pacific people screening from age 50 — so about 100,000 Māori and Pasifika aged 50–58 lost earlier access to pay for the universal drop to 58 (RNZ).

Who it is for, and why — following the trail:

• The target is clear in the data: bowel cancer strikes Māori younger (58% of cases in Māori women and 52% in Māori men appear before 60, versus 27–29% for non-Māori), they are diagnosed later (metastatic at diagnosis — Māori 31.6%, Pacific 34.9%, others 22.8%), and they screen less (national participation: European 62%, Māori 50%, Pacific 39%). That is why screening is promoted specifically to Māori and Pacific communities (colorectal research, bowel-screening study).
• Follow the trail upstream and the causes are structural, not personal. Lower participation reflects access barriers — referral of younger adults, diagnostic delays, workforce and specialist shortages, and spoilt test kits six times more likely for Pacific peoples. The diet link runs through the food environment and cost of living: fruit and vegetable prices have risen faster than processed and sweetened food, so the cheapest calories are increasingly the least healthy; takeaway and discretionary foods make up 30–40% of current-diet costs; and food insecurity is far higher for Māori and Pacific — about 35% of Māori children live in food-insecure households (The Conversation). The chain runs: deprivation and time/cost pressure → a cheaper, less healthy food environment → higher diet-related risk → compounded by lower screening and later diagnosis → worse survival.

Other levers beyond diet:

Smoking and alcohol are major modifiable causes of bowel cancer — in NZ about 7% of cases are attributable to alcohol and 3% to smoking — and Māori smoking rates (18–20%) run about three times the European rate. So the 2024 repeal of the smokefree generation laws, which would have cut smoking most among Māori, pulls against prevention. (For accuracy: Māori have lower overall bowel-cancer incidence than non-Māori, but higher mortality, driven by later diagnosis.)

Related issues: the smokefree repeal and the Māori Health Authority disestablishment.

The result (kept, but contested):

The age did drop to 58, so on its face the promise is kept — but it was funded by removing the very age-50 access aimed at the group that develops bowel cancer youngest and screens least. That is why it drew fierce criticism: Dr Nina Scott of the Māori Cancer Leadership Network called it "institutionalised racism", the Royal Australasian College of Surgeons called it a step back for Māori health, a Human Rights Commission complaint alleged indirect discrimination, and an NZ Medical Journal editorial branded the response inadequate (RACS). The determinants make the trade-off starker: screening is downstream mitigation, while the biggest gains lie upstream — lifting Māori and Pacific participation (the targeted campaigns), earlier access for high-risk groups, and food-affordability and access measures. Verdict: a universal lowering delivered by cutting a targeted equity programme — kept, but arguably shifting resources away from where the data says the need is greatest.